Literature DB >> 9673445

Special article: non-invasive measurement of endothelial function.

D A Playford1, G F Watts.   

Abstract

1. Endothelial dysfunction, due to reductions in nitric oxide (NO) action, is an early feature of macrovascular disease. 2. Non-invasive measurement of endothelial function may be assessed by postischaemic dilation of forearm vessels, using plethysmography, or flow-mediated dilatation of the brachial artery, using ultrasound. 3. Brachial flow-mediated dilatation reflects NO release and/or action more than forearm hyperaemia. 4. These techniques have been used as surrogate measures of coronary endothelial function. 5. Methodological, physiological and clinical aspects of the techniques are discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9673445     DOI: 10.1111/j.1440-1681.1998.tb02269.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  4 in total

Review 1.  Fetal roots of cardiac disease.

Authors:  K L Thornburg; S Louey
Journal:  Heart       Date:  2005-07       Impact factor: 5.994

2.  A high-fat diet induces and red wine counteracts endothelial dysfunction in human volunteers.

Authors:  A M Cuevas; V Guasch; O Castillo; V Irribarra; C Mizon; A San Martin; P Strobel; D Perez; A M Germain; F Leighton
Journal:  Lipids       Date:  2000-02       Impact factor: 1.646

3.  The relation between endothelial dependent flow mediated dilation of the brachial artery and coronary collateral development - a cross sectional study.

Authors:  Aydan Ongun Ozdemir; Sadi Gulec; Nihal Uslu; Cansin Tulunay Kaya; Cagdas Ozdol; Sibel Turhan; Yusuf Atmaca; Timucin Altin; Cetin Erol
Journal:  Cardiovasc Ultrasound       Date:  2009-06-15       Impact factor: 2.062

4.  Bradykinin or acetylcholine as vasodilators to test endothelial venous function in healthy subjects.

Authors:  Eneida R Rabelo; Luis E Rohde; Beatriz D Schaan; Marcelo C Rubira; Karen B Ruschel; Rodrigo D M Plentz; Fernanda M Consolim-Colombo; Maria Cláudia Irigoyen; Heitor Moreno Junior
Journal:  Clinics (Sao Paulo)       Date:  2008-10       Impact factor: 2.365

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.